vs

Side-by-side financial comparison of Ispire Technology Inc. (ISPR) and 908 Devices Inc. (MASS). Click either name above to swap in a different company.

Ispire Technology Inc. is the larger business by last-quarter revenue ($20.3M vs $17.4M, roughly 1.2× 908 Devices Inc.). 908 Devices Inc. runs the higher net margin — 24.0% vs -32.5%, a 56.6% gap on every dollar of revenue. On growth, 908 Devices Inc. posted the faster year-over-year revenue change (21.2% vs -51.5%). 908 Devices Inc. produced more free cash flow last quarter ($1.3M vs $-4.0M). Over the past eight quarters, 908 Devices Inc.'s revenue compounded faster (53.0% CAGR vs -17.8%).

Ispire Technology Inc. is a global tech firm specializing in R&D, manufacturing and sales of advanced vaporization hardware and supporting consumables. It serves nicotine and legal cannabis consumer markets, operates two core segments of hardware and branded cannabis products, covers North America, Europe and Asia-Pacific, delivering compliant innovative vapor solutions for B2B partners and end users.

908 Devices Inc. develops and manufactures portable, high-performance mass spectrometry devices and analytical solutions. Its products serve use cases across life science research, biopharmaceutical manufacturing, public safety, forensics, and industrial process monitoring, catering to global customers including research institutions, pharmaceutical firms and government agencies.

ISPR vs MASS — Head-to-Head

Bigger by revenue
ISPR
ISPR
1.2× larger
ISPR
$20.3M
$17.4M
MASS
Growing faster (revenue YoY)
MASS
MASS
+72.7% gap
MASS
21.2%
-51.5%
ISPR
Higher net margin
MASS
MASS
56.6% more per $
MASS
24.0%
-32.5%
ISPR
More free cash flow
MASS
MASS
$5.3M more FCF
MASS
$1.3M
$-4.0M
ISPR
Faster 2-yr revenue CAGR
MASS
MASS
Annualised
MASS
53.0%
-17.8%
ISPR

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
ISPR
ISPR
MASS
MASS
Revenue
$20.3M
$17.4M
Net Profit
$-6.6M
$4.2M
Gross Margin
17.1%
52.7%
Operating Margin
-33.9%
17.8%
Net Margin
-32.5%
24.0%
Revenue YoY
-51.5%
21.2%
Net Profit YoY
17.4%
121.5%
EPS (diluted)
$-0.12
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ISPR
ISPR
MASS
MASS
Q4 25
$20.3M
$17.4M
Q3 25
$30.4M
$14.0M
Q2 25
$20.1M
$13.0M
Q1 25
$26.2M
$11.8M
Q4 24
$41.8M
$14.3M
Q3 24
$39.3M
$14.5M
Q2 24
$37.3M
$11.5M
Q1 24
$30.0M
$7.4M
Net Profit
ISPR
ISPR
MASS
MASS
Q4 25
$-6.6M
$4.2M
Q3 25
$-3.3M
$-15.0M
Q2 25
$-14.8M
$-13.3M
Q1 25
$-10.9M
$43.6M
Q4 24
$-8.0M
$-19.4M
Q3 24
$-5.6M
$-29.3M
Q2 24
$-3.5M
$-12.5M
Q1 24
$-5.9M
$-10.9M
Gross Margin
ISPR
ISPR
MASS
MASS
Q4 25
17.1%
52.7%
Q3 25
17.0%
52.5%
Q2 25
12.3%
48.9%
Q1 25
18.2%
47.0%
Q4 24
18.5%
46.5%
Q3 24
19.5%
53.6%
Q2 24
28.3%
53.8%
Q1 24
20.4%
52.4%
Operating Margin
ISPR
ISPR
MASS
MASS
Q4 25
-33.9%
17.8%
Q3 25
-8.9%
-116.6%
Q2 25
-72.7%
-116.3%
Q1 25
-40.4%
-93.6%
Q4 24
-17.6%
-116.8%
Q3 24
-13.4%
-168.7%
Q2 24
-9.2%
-74.5%
Q1 24
-18.8%
-102.5%
Net Margin
ISPR
ISPR
MASS
MASS
Q4 25
-32.5%
24.0%
Q3 25
-10.7%
-107.0%
Q2 25
-73.4%
-102.1%
Q1 25
-41.5%
370.2%
Q4 24
-19.1%
-135.6%
Q3 24
-14.2%
-201.8%
Q2 24
-9.4%
-109.5%
Q1 24
-19.7%
-147.1%
EPS (diluted)
ISPR
ISPR
MASS
MASS
Q4 25
$-0.12
$0.09
Q3 25
$-0.06
$-0.41
Q2 25
$-0.26
$-0.37
Q1 25
$-0.19
$1.23
Q4 24
$-0.14
$-0.58
Q3 24
$-0.10
$-0.84
Q2 24
$-0.07
$-0.37
Q1 24
$-0.11
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ISPR
ISPR
MASS
MASS
Cash + ST InvestmentsLiquidity on hand
$17.6M
$113.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$-7.7M
$143.7M
Total Assets
$84.4M
$190.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ISPR
ISPR
MASS
MASS
Q4 25
$17.6M
$113.0M
Q3 25
$22.7M
$112.1M
Q2 25
$24.4M
$118.6M
Q1 25
$23.5M
$124.3M
Q4 24
$34.4M
$69.6M
Q3 24
$37.7M
$71.7M
Q2 24
$35.1M
$77.4M
Q1 24
$39.5M
$134.2M
Stockholders' Equity
ISPR
ISPR
MASS
MASS
Q4 25
$-7.7M
$143.7M
Q3 25
$-1.8M
$136.3M
Q2 25
$604.7K
$148.8M
Q1 25
$14.8M
$159.4M
Q4 24
$24.2M
$114.6M
Q3 24
$30.7M
$131.0M
Q2 24
$34.5M
$156.4M
Q1 24
$35.9M
$156.9M
Total Assets
ISPR
ISPR
MASS
MASS
Q4 25
$84.4M
$190.1M
Q3 25
$96.4M
$190.9M
Q2 25
$102.2M
$191.7M
Q1 25
$115.7M
$196.0M
Q4 24
$132.0M
$159.5M
Q3 24
$129.0M
$178.3M
Q2 24
$122.6M
$208.8M
Q1 24
$108.0M
$189.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ISPR
ISPR
MASS
MASS
Operating Cash FlowLast quarter
$-4.0M
$1.3M
Free Cash FlowOCF − Capex
$-4.0M
$1.3M
FCF MarginFCF / Revenue
-19.9%
7.6%
Capex IntensityCapex / Revenue
0.3%
0.0%
Cash ConversionOCF / Net Profit
0.32×
TTM Free Cash FlowTrailing 4 quarters
$-14.2M
$-24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ISPR
ISPR
MASS
MASS
Q4 25
$-4.0M
$1.3M
Q3 25
$-1.2M
$-4.2M
Q2 25
$4.7M
$-5.8M
Q1 25
$-12.5M
$-15.0M
Q4 24
$-3.2M
$-2.2M
Q3 24
$3.6M
$-5.6M
Q2 24
$-1.4M
$-13.0M
Q1 24
$3.4M
$-9.4M
Free Cash Flow
ISPR
ISPR
MASS
MASS
Q4 25
$-4.0M
$1.3M
Q3 25
$-1.2M
$-4.9M
Q2 25
$3.7M
$-5.9M
Q1 25
$-12.7M
$-15.2M
Q4 24
$-3.2M
$-2.4M
Q3 24
$3.3M
$-5.8M
Q2 24
$-2.2M
$-13.7M
Q1 24
$3.3M
$-10.3M
FCF Margin
ISPR
ISPR
MASS
MASS
Q4 25
-19.9%
7.6%
Q3 25
-3.9%
-34.9%
Q2 25
18.6%
-45.3%
Q1 25
-48.4%
-128.9%
Q4 24
-7.7%
-17.0%
Q3 24
8.5%
-39.7%
Q2 24
-5.9%
-119.4%
Q1 24
10.9%
-138.2%
Capex Intensity
ISPR
ISPR
MASS
MASS
Q4 25
0.3%
0.0%
Q3 25
0.0%
4.9%
Q2 25
4.8%
0.9%
Q1 25
0.7%
1.4%
Q4 24
0.1%
1.3%
Q3 24
0.7%
1.1%
Q2 24
2.0%
5.6%
Q1 24
0.3%
12.2%
Cash Conversion
ISPR
ISPR
MASS
MASS
Q4 25
0.32×
Q3 25
Q2 25
Q1 25
-0.34×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ISPR
ISPR

Segment breakdown not available.

MASS
MASS

Products$14.3M82%
Services$3.0M18%

Related Comparisons